Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy
Tonino Alonzi(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Delia Goletti(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Alessandra Aiello(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Manuela D’Eletto(University of Rome Tor Vergata), Mauro Piacentini(University of Rome Tor Vergata), Giovanni Delogu(Università Cattolica del Sacro Cuore), Saeid Najafi Fard(Sapienza University of Rome), Giuseppe Ippolito(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Maria Rosaria Capobianchi, Linda Petrone(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Laura Falasca(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Roberta Nardacci(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Federica Rossin(University of Rome Tor Vergata), Concetta Castilletti(Czech Academy of Sciences)
Cited by 17
Related Papers
Molecular definitions of autophagy and related processes
|The EMBO Journal|2017|1.6k
Autophagy in major human diseases
|The EMBO Journal|2021|1.6k
Self-Reported Symptoms and Medication Side Effects Influence Adherence to Highly Active Antiretroviral Therapy in Persons With HIV Infection
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2001|470
The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination
|Nature|2001|464
Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact
|Journal of Infection|2020|445